1. |
Karahuseyinoglu S, Cinar O, Kilic E, et al. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells, 2007, 25(2): 319- 331.
|
2. |
Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica, 2006, 91(8): 1017-1026.
|
3. |
Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells, 2007, 25(6): 1384-1392.
|
4. |
Anzalone R, Lo Iacono M, Corrao S, et al. New emerging potentials for human Wharton’s jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev, 2010, 19(4): 423-438.
|
5. |
Han Y, Chai J, Sun TJ, et al. Differentiation of human umbilical cord mesenchymal stem cells into dermal fibroblasts in vitro. Biochem Biophys Res Commun, 2011, 413(4): 561-565.
|
6. |
Colotta F, Sciacca FL, Sironi M, et al. Expression of monocyte chemotactic protein-l by monocytes and endothelial cells exposed to thrombin. Am J Pathol, 1994, 144(5): 975-985.
|
7. |
Sasaki M, Abe R, Fujita Y, et al. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol, 2008, 180(4): 2581-2587.
|
8. |
Yoshikawa T, Mitsuno H, Nonaka I, et al. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg, 2008, 121(3): 860-877.
|
9. |
Shohara R, Yamamoto A, Takikawa S, et al. Mesenchymal stromal cells of human umbilical cord Wharton’s jelly accelerate wound healing by paracrine mechanisms. Cytotherapy, 2012, 14(10): 1171-1181.
|
10. |
Kim JW, Lee JH, Lyoo YS, et al. The effects of topical mesenchymal stem cell transplantation in canine experimental cutaneous wounds. Vet Dermatol, 2013, 24(2): 242-e53.
|
11. |
Majore I, Moretti P, Hass R, et al. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun Signal, 2009, 7: 6.
|
12. |
Copeland N, Harris D, Gaballa MA. Human umbilical cord blood stem cells, myocardial infarction and stroke. Clin Med, 2009, 9(4): 342-345.
|
13. |
Wu KH, Mo XM, Zhou B, et al. Cardiac potential of stem cells from whole human umbilical cord tissue. J Cell Biochem, 2009, 107(5): 926-932.
|
14. |
Yang CC, Shih YH, Ko MH, et al. Transplantation of human umbilical mesenchymal stem cells from Wharton’s jelly after complete transection of the rat spinal cord. PLoS One, 2008, 3(10): e3336.
|
15. |
Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol, 2007, 213(2): 341-347.
|
16. |
Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther, 2008, 10(5): 223.
|
17. |
Németh K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med, 2009, 15(1): 42-49.
|
18. |
胡克蘇, 張逸, 顧志峰, 等. 燒傷患者血清對骨髓間充質干細胞生物學特性的影響. 交通醫學, 2011, 25(1): 14-16.
|
19. |
Mumme M, Scotti C, Papadimitropoulos A, et al. Interleukin-1β modulates endochondral ossification by human adult bone marrow stromal cells. Eur Cell Mater, 2012, 24: 224-236.
|
20. |
Carrero R, Cerrada I, Lledó E, et al. IL1β induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-κB. Stem Cell Rev, 2012, 8(3): 905-916.
|
21. |
Hu C, Wu Y, Wan Y, et al. Introduction of hIGF-1 gene into bone marrow stromal cells and its effects on the cell’s biological behaviors. Cell Transplant, 2008, 17(9): 1067-1081.
|
22. |
Gruber HE, Norton HJ, Hanley EN Jr. Anti-apoptotic effects of IGF-1 and PDGF on human intervertebral disc cells in vitro. Spine (Phila Pa 1976), 2000, 25(17): 2153-2157.
|
23. |
Li W, Ma N, Ong LL, et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells, 2007, 25(8): 2118-2127.
|
24. |
Hu X, Yu SP, Fraser JL, et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg, 2008, 135(4): 799-808.
|